Trial Profile
Efficacy of batroxobin and aspirin, for the prevention of restenosis, in diabetic patients with symptomatic infrapopliteal obstructions who have undergone angioplasty.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Jan 2011
Price :
$35
*
At a glance
- Drugs Batroxobin (Primary) ; Aspirin
- Indications Embolism and thrombosis; Peripheral arterial occlusive disorders; Vascular restenosis
- Focus Therapeutic Use
- 13 Jan 2011 New trial record